NeoBar

ET Tube Holder with Gentle Hydrocolloid Adhesive Tabs

Features & Benefits

  • Attaches to patients with latex free NeoBond® hydrocolloid
  • Reduces extubations and helps prevent palate trauma
  • Available in 7 color coded sizes for babies as small as 400 grams
  • No tape near nose or mouth, allows for better oral care
  • Standardizes application procedures and prevents frequent tape changes
  • Easily removed in case of emergency
  • NOW available in larger sizes for larger/pediatric patients!
  • Please note, “H” stands for hydrocolloid. “F” stands for “foam”. Larger sizes of the NeoBar are available in traditional hydrocolloid, or with a medical grade adhesive/foam that is suitable for more mature skin. Hydrocolloid should be used on neonatal patients.
  • Transport box available! Catalog #N718, includes sizes N709-N714
  • Not made with natural latex rubber
  • Not made with plasticizer DEHP

Order Sample

Clear selection

AUDIT OF A NEW NEONATAL ENDOTRACHEAL TUBE FIXATION DEVICE – THE NEOBAR®

Neonatal Intensive Care Unit, United Kingdom

AIMS

To determine the efficacy of a new neonatal endotracheal tube fixation device by evaluating the prevalence of known complications associated with its use during a five month trial period on the neonatal intensive care unit.

METHOD

Nursing and medical staff completed an evaluation sheet following each initial intubation, and on each subsequent day that the neonate remained intubated. The evaluation sheet contained a number of questions aimed at determining the occurrence of known complications associated with the device, as well as space for free text to highlight new complications.

RESULTS

During the five month period 117 neonates were admitted to the neonatal unit. Thirteen neonates required intubation, a total of twenty two intubations in all. Data was obtained on all twenty two intubations. The correct size NeoBarwas used in 21/22 (95.5%) intubations. Difficulty in securing the endotracheal tube to the NeoBardevice was reported in one case (4.5%), with difficulty adhering the device to the neonate’s skin in 4/22 (18.2%) cases. Concerns regarding a lack of adhesiveness of the device to the skin were recorded on day 1 (17.6%), day 2 (36.4%), and day 3 (33.3%) of intubation. Concerns regarding rubbing of the endotracheal tube against the neonate’s lip were recorded on day 1 (5.9%), day 2 (36.4%) and day 3 (33.3%). Concerns that the NeoBar device was becoming detached from the endotracheal tube were recorded on day 1 (23.5%), day 2 (18.2%) and day 3 (33.3%). In no cases did any of these recorded concerns require any action to resolve.

CONCLUSION

The NeoBar is a safe and effective device used for fixing endotracheal tubes on the neonatal intensive care unit. Complications, principally concerning loss of adhesion of the device to the skin or the endotracheal tube, and rubbing of the endotracheal tube against the neonate’s lip were more prevalent the longer the neonate was intubated, but never resulted in the need to change the device or reintubate. As a result of our audit, all endotracheal tubes on our neonatal intensive care unit are now fixed using the NeoBar device.



NeoBar Poster
Download NeoBar Inservice Poster